Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
St. Jude Children's Research Hospital · NCT01354002
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100000
- US sites recruiting
- 13
- Study start
- September 1, 2009
- Record last updated
- April 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The aims of this protocol are: to collect and store diseased and normal tissue and body fluid samples from new and returning patients at St. Jude Children's Research Hospital (SJCRH), affiliated sites and collaborating institutions; to collect and store samples from relatives of SJCRH patients; to collect and store retrospective and prospective pertinent corresponding clinical and laboratory data on disease characterization, treatment, and outcome; and to serve as a source of human biological samples and corresponding laboratory and clinical data.
Conditions: Normal and Diseased Tissue and Body Fluids Samples
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patients (and their relatives) and control populations treated or studied at SJCRH and SJCRH affiliates and collaborating sites that have IRB approval for TBANK with malignant and non-malignant conditions.
- Patients from institutions that do not have Institutional Review Board (IRB) approval for TBANK, and at which a banking mechanism may not be established, who provide samples for research at St. Jude and from whom consent for TBANK is obtained by the TBANK principal investigator (PI).
- Samples from employees of St. Jude Children's Research Hospital (SJCRH) collected for public health surveillance studies (e.g. SJTRC-NCT04362995) provided the employees have consented to participate in the specific IRB-approved studies.
Exclusion Criteria
- Patients from institutions that do not have IRB approval for TBANK, and who have not provided consent for TBANK, or patients not enrolled on SJCRH protocols that incorporate consent for tumor banking.
Recruiting US locations
St. Jude Clinic at Huntsville Hospital for Women & Children
Huntsville, AL 35801
Site contact: Marla Daves, MD · 256-265-5833 · Marla.Daves@hhsys.org
Lucile Packard Children's Hospital Stanford University
Palo Alto, CA 94305
Site contact: Norman J. Lacayo, MD · 650-723-5535 · lacayon@stanford.edu
Rady Children's Hospital and Health Center
San Diego, CA 92123
Site contact: Deborah Schiff, MD · 858-966-5983
Children's Hospital of Illinois at OSF-Saint Francis Medical Center
Peoria, IL 61637
Site contact: Mary Beth Ross, MD · 309-624-4945
Our Lady of the Lake Regional Medical Center
Baton Rouge, LA 70808
Site contact: Jeffrey Deyo, MD · 225-763-6337
Louisiana State University Health Sciences Center
Shreveport, LA 71130-3932
Site contact: Ayobami Olanrewaju, MBBS · 318-626-0772 · Ayobami.Olanrewaju@lsuhs.edu
Mercy Children's Hospital - Springfield
Springfield, MO 65804
Site contact: Francisca R. Fasipe, MD · 877-700-2110
St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital
Charlotte, NC 28204
Site contact: Christine Bolen, MD · 704-384-1900 · Cybolen@novanthealth.org
St. Jude Affiliate Clinic at Saint Francis Children's Hospital
Tulsa, OK 74136
Site contact: Ashraf Mohamed, MD, MHA, PhD · 918-851-1924 · AmMohamed@saintfrancis.com
Johnson City Medical Center
Johnson City, TN 37604
Site contact: Marcela Popescu, MD · 423-431-3950
LeBonheur Children's Hospital
Memphis, TN 38103
Site contact: Charles Mullighan, MBBS, MD · 901-287-5437
St. Jude Children's Research Hospital
Memphis, TN 38105
Site contact: Charles Mulligan, MBBS, MD · 888-226-4343 · referralinfo@stjude.org
Cook Children's Medical Center
Fort Worth, TX 76104
Site contact: Kenneth M. Heym, MD · 682-885-4007
Study contacts (from the official record)
- Charles Mullighan, MBBS, MD · 901-595-3387 · charles.mullighan@stjude.org
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65